Elsevier

Journal of Neuroimmunology

Volume 346, 15 September 2020, 577326
Journal of Neuroimmunology

Short Communication
Hemorrhagic encephalopathy associated with COVID-19

https://doi.org/10.1016/j.jneuroim.2020.577326Get rights and content

Highlights

  • COVID-19 is a rapidly evolving and deadly global pandemic.

  • Cytokine storm syndromes have been proposed as a cause for severe disease.

  • Neurological manifestations of COVID-19 are an area of active research.

  • Pro-inflammatory CSF cytokine dysregulation may mediate hemorrhagic encephalopathy.

  • Vigilance for this clinical condition is required as COVID-19 continues to spread.

Abstract

The mechanisms for neurological complications of COVID-19, the disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), are not yet well understood. We present a critically ill man with a COVID-19-associated hemorrhagic encephalopathy. SARS-CoV-2 RNA was not detected in cerebrospinal fluid (CSF) or blood. CSF analyses suggested dysregulation of pro-inflammatory cytokine pathways, particularly tumor necrosis factor-α and interleukin-6, consistent with a cytokine release syndrome. The patient gradually recovered with supportive care and neurological rehabilitation. Awareness of this clinical entity may facilitate the identification of patients with a potentially remediable cause of encephalopathy in COVID-19.

Keywords

COVID-19
Encephalopathy
SARS-CoV-2
Coronavirus
Intracerebral hemorrhage

Cited by (0)

View Abstract